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Abstract 
4’-Ethynyl-4-n-[2,3-3H,lpropylbicycloorthobenzoate (13HlEBOB) binding to the GABA, receptor complex was characterized 
autoradiographically in rat brain and then its binding in human brain was investigated. [ 3H]EBOB binding was saturable, specific 
and identified a single population of binding sites. The K, obtained from saturation studies was 4.59 nM. Picrotoxin produced 
dose-dependent inhibition of [ 3H]EBOB binding and saturation analysis indicated a competitive interaction. Isoguvacine 
inhibited [3H]EBOB binding with regionally different effects. Bicuculline increased [3H]EBOB binding only in the cerebellar 
granule cell layer. In human cerebellum, a high level of t3H]EBOB binding sites was seen in the granule cell layer. These results 
suggest that [3H]EBOB binds to the picrotoxin binding site associated with the GABA, receptor complex, that regional 
differences in GABA, agonist and antagonist modulation of [3H]EBOB binding reflect underlying regional differences in 
GABA, receptor subunit composition, and that there is a species difference in GABA, receptor distribution between human 
and rat cerebellum. 
Keywords: EBOB (4’-ethynyl-4-n-propylbicycloorthobenzoate); GABA, receptor complex; Picrotoxin; Brain, human; Autoradio- 
grapby 
1. Introduction 
The GABA, receptor is the major mediator of 
synaptic inhibition in the central nervous system and 
structurally is a hetero-oligomeric protein comprised of 
five (or fewer) subunits per active complex (Burt and 
Kamatchi, 1991). Molecular cloning studies have pro- 
vided evidence for the existence of a number of differ- 
ent subunits forming the GABA, receptor and each of 
these subunits has a distinct regional distribution in the 
brain (Olsen and Tobin, 1990; Burt and Kamatchi, 
1991; 
* Corresponding author. Tel. 313-764-1347, fax 313-764-2189. 
0014-2999/94/$07.00 0 1994 Elsevier Science B.V. All rights reserved 
SSDIOO14-2999(94)00418-8 
Among the several binding sites of the GABA, 
receptor complex, a site of particular interest is the 
picrotoxin site. In binding studies, picrotoxin ligand 
binding is regulated by the activation of other sites on 
the GABA, receptor complex. GABA, agonists and 
zinc inhibit picrotoxin ligand binding (Squires et al., 
1983; Lawrence et al., 1985; Edgar and Schwartz, 1990; 
Kume et al., 1994; Sakurai et al., 1994). Benzodi- 
azepines and neurosteroids have complex effects (Gee 
et al., 1986, 1988, 1989; Lloyd et al., 1990; Im and 
Blakeman, 1991; Concas et al., 1990; Sakurai et al., 
1994). The regulation of picrotoxin ligand binding by 
other sites on the GABA, receptor complex allows 
picrotoxin ligand binding assays to be used as func- 
tional probes of GABA, receptor function and phar- 
macology. 
The picrotoxin site on the GABA, receptor com- 
plex has been characterized with [ 3H]a-dihydropicro- 
toxinin (Ticku et al., 19781, [ 35S]t-butylbicyclophos- 
phorothionate ([35S]TBPS> (Lawrence and Casida, 
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1983; Squires et al., 1983; Ramanjaneyulu and Ticku, 
1984; Edgar and Schwartz, 1990) and [3H]t-butylbi- 
cycloorthobenzoate ([3H]TBOB)(Lawrence et al., 1985; 
Van Rijn et al., 1990; Sakurai et al., 1994). [3H]a-Dihy- 
dropicrotoxinin suffered from low specific binding and 
low affinity and is no longer used. [35S]TBPS is greatly 
improved in specific binding and affinity, and has been 
used most commonly for both homogenate and auto- 
radiographic binding experiments. A disadvantage of 
[35S]TBPS is the short half-life of the radiolabel and a 
poorer degree of resolution than tritiated ligands when 
used for film autoradiography. [3H]TBOB is a less 
costly alternative to [3sS]TBPS and has been used in 
homogenate and autoradiographic studies. Recently, a 
new tritiated ligand was introduced, [3H]4'-ethynyl-4-n- 
[2,3-3H2]propylbicycloorthobenzoate ([3H]EBOB) 
(Palmer and Casida, 1991; Deng et al., 1991; Cole and 
Casida, 1992; Hawkinson and Casida, 1992). EBOB is 
structurally related to TBOB. The specific binding is 
approximately 90% of total binding and the reported 
K d of [3H]EBOB is approximately 2 nM which is 
almost one tenth of that of [3H]TBOB (Cole and 
Casida, 1992). The high affinity, high specific binding, 
and high specific activity of [3H]EBOB predict that 
[3H]EBOB is an excellent ligand for autoradiographic 
studies. Although several investigators have used 
[3H]EBOB to study GABAA receptors in brain ho- 
mogenates, characterization of [3H]EBOB binding for 
quantitative autoradiography has not been reported. 
In this study, we have characterized [3H]EBOB 
binding to rat brain slices for quantitative autoradiog- 
raphy, determined the effect of compounds acting at 
the GABA A receptor complex, and determined the 
distribution of [3H]EBOB binding sites in the rat brain. 
In addition, we have investigated [3H]EBOB auto- 
radiography in human brain. 
2. Materials and methods 
2.1. Subjects 
Male Sprague-Dawley rats (Harlan Labs, Indianapo- 
lis, IN, USA; weight, 175-199 g) were decapitated, 
their brains rapidly removed, mounted on cryotome 
chunks, and frozen in Lipshaw embedding matrix sur- 
rounded by powdered dry ice. 20 /zm-thick sections 
were cut in the horizontal plane on a Lipshaw cryostat. 
Sections were obtained at the level including the 
caudo-putamen, and thaw-mounted onto 2 x subbed 
gelatin-coated slides on a warming plate and stored at 
- 2 0 ° C  until the time of assay. All assays were per- 
formed 24 h after decapitation. Each experiment was 
run in triplicate. 
Six human cerebellar hemispheres from individuals 
without neurologic diseases were obtained at necropsy, 
sectioned in a sagittal plane into 1 cm slabs, frozen in 
crushed dry ice, placed in sealed plastic bags, and 
stored at -70°C. The average postmortem delay to 
storage was 17.2 h (range, 7-23 h), and the average age 
at death was 49.3 years (range, 24-80 years). At the 
time of assay, slabs were warmed overnight to -20°C 
and blocks containing the cerebellar cortex were cut 
out of the slabs. Blocks were mounted on cryotome 
chunks, and 20/~m-thick sections were cut sagittally on 
a Lipshow cryostat. Sections were thaw-mounted onto 
2 x subbed gelatin-coated slides and stored at -20°C 
until assay. Assays were run 24 h after sectioning. 
2.2. [3H]EBOB binding 
Slide-mounted tissue sections were warmed to room 
temperature and prewashed for 3 x 10 min in buffer 
(50 mM Tris-HCl + 1 mM EDTA pH 7.4 at 4°C) and 
dried under a stream of cool air. Binding of [3H]EBOB 
(2 nM) was carried out in buffer (50 mM Tris-HCl + 120 
mM NaC1 pH 7.4 at room temperature) for 120 min at 
room temperature. The incubation was terminated by 
two 60 min rinses in buffer (50 mM Tris-HCl pH 7.4 at 
4°C) at 4°C followed by a brief dip in distilled water. 
Each slide was then dried under a stream of hot air. 
Non-specific binding was assessed in the presence of 20 
/zM picrotoxin. Autoradiograms were generated by ap- 
posing the slides to tritium-sensitive film (Hyperfilm, 
Amersham) in light-tight cassettes along with standards 
containing known amounts of radioactivity. After 3 
weeks, films were developed in Kodak D-19. Ligand 
binding was quantitated with computer-assisted den- 
sitometry using the MCID system (Imaging Research, 
St. Catherines, Ontario, Canada). To quantify ligand 
binding density, the optical density of co-exposed 
standards was determined and a standard curve gener- 
ated by fitting standard values with a fourth-degree 
polynomial regression equation. Standards were com- 
mercial 14C plastic standards (ARC, St. Louis, MO, 
USA). Use of the standards and derived standard 
curve allows conversion of areal optical density to 
pmol/mg protein values. Areas read included the cor- 
tical laminae I-III, lamina IV and laminae V-VI, hip- 
pocampal CA1 stratum oriens, CA1 stratum radiatum, 
CA3 stratum oriens, CA3 stratum radiatum and den- 
tate gyrus, striatum, thalamus (laterodorsal thalamic 
nucleus and lateral posterior thalamic nucleus), sep- 
tum, superior colliculus, inferior colliculus, periaque- 
ductal gray matter, and cerebellar molecular and gran- 
ule cell layers. Ten to twenty readings per area from 
triplicate sections were averaged. 
Optimal prewashing was determined by using 2 dif- 
ferent prewashing regimens: 3 x 10 min washed in 50 
mM Tris-HCl (pH 7.4 at 4°C), 3 x 10 min washes in 50 
mM Tris-HCl + 1 mM EDTA (pH 7.4 at 4°C). Sections 
were then processed as described above using 2 nM 
[3H]EBOB. 
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For association experiments, sections were incu- 
bated in assay buffer containing 2 nM [3H]EBOB for 
12 time points between 2 and 360 min, and rinsed as 
described above. 
For saturation studies, sections were incubated in 10 
concentrations of [3H]EBOB ranging from 10 pM to 10 
nM. Non-specific binding was assessed with addition of 
200/zM picrotoxin. Films were analyzed as described 
above and data further analyzed with Scatchard plots. 
2.3. Effects of  picrotoxin, isoguvacine and bicuculline 
To determine the regulation of [3H]EBOB binding 
by GABA A ligands, unlabelled drugs were included in 
the incubation mixture with 2 nM [3H]EBOB. Drugs 
evaluated included: 1 nM to 10 ~M picrotoxin, 1 nM to 
100 /xM isoguvacine, 1 /xM to 1 mM bicuculline 
methobromide. IC50 values for competitors were calcu- 
lated by log-logit analysis. The interaction of picrotoxin 
with [3H]EBOB was further examined by performing 
saturation analysis as described above in the presence 
of 600 nM picrotoxin. 
2.4. Regional distribution of  [3H]EBOB binding sites 
The regional distribution of [3H]EBOB binding sites 
was established using horizontal sections cut at the 
level including the caudo-putamen. Sections were pro- 
cessed for [3H]EBOB autoradiography as described 
above using 2 nM [3H]EBOB. We compared the re- 
gional distribution of [3H]EBOB with that of [3H]- 
TBOB. [3H]TBOB autoradiography was performed as 
described previously (Kume et al., 1994; Sakurai et al., 
1994) using 20 nM [3H]TBOB. Correlation of the re- 
gional distribution of [3H]EBOB binding sites with the 
regional distribution of [3H]TBOB was determined with 
linear regression. 
2.5. Human cerebellar cortex 
Human cerebellar sections were processed for 
[3H]EBOB autoradigraphy as described above using 2 
nM [3H]EBOB. To compare [3H]EBOB binding with 
[3H]TBOB binding, [3H]TBOB autoradiography was 
performed as described previously (Kume et al., 1994; 
Sakurai et al., 1994) using 20 nM [3H]TBOB. In gener- 
ating autoradiograms, sections were exposed to tritium- 
sensitive film for 5 weeks. 
2. 6. Materials 
4'-Ethynyl-4-n-[2,3- 3H 2 ]propylbicycloorthobenzoate 
([3H]EBOB, specific activity = 50.5 Ci/mmol) was pur- 
chased from Dupont New England Nuclear (Boston, 
MA, USA) and [3H]t-butylbicycloorthobenzoate ([3H]- 
TBOB, specific activity = 25.0 Ci/mmol) from Amer- 
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Fig. 1. Association curve for specific [3H]EBOB binding to cortical 
lamina IV. Rat brain sections were incubated in 2 nM [3H]EBOB for 
12 time points and then rinsed for 2x60 min in buffer. Data 
represent mean + S.E.M. of 3 animals. 
sham (Arlington Heights, IL, USA). Isoguvacine was 
purchased from Cambridge Research Biochemicals 
(Cambridge, UK). Bicuculline and picrotoxin were pur- 
chased from Research Biochemicals (Natick, MA, 
USA). The remaining reagents were purchased from 
Sigma Chemicals (St. Louis, MO, USA) and were of 
the highest possible purity. 
3. Results 
3.1. [SH]EBOB binding 
Prewashing in buffer containing 1 mM EDTA pro- 
vided specific [3H]EBOB binding of 1.13 + 0.077 
pmol/mg protein (mean + S.E.M.) in cortical lamina 
IV, which is 1.5 times as high as that prewashed in 
buffer without EDTA. Therefore, in all experiments 
slices were prewashed in buffer containing 1 mM 
EDTA. Specific binding of [3H]EBOB was 99% of 
total binding when sections received 2 × 60 min rinses 
in 50 mM Tris-HCl (pH 7.4 at 4°C). 
In association experiments, specific [3H]EBOB bind- 
ing increased with increasing incubation time and 
steady state was reached by 2 h of incubation at room 
temperature (Fig. 1). Specific binding was stable at 
incubation times up to 4 h but declined variably after 
longer incubation times, apparently due to degenera- 
tion of the slide-mounted tissue. Therefore, slices were 
incubated with [3H]EBOB for 2 h in equilibrium-bind- 
ing experiments. 
Saturation experiments showed that specific [3H]- 
EBOB binding sites were occupied with 7 nM [3H]- 
EBOB (Fig. 2A). Non-specific binding was linear over 
the range of [3H]EBOB concentrations used and the 
percentage of non-specific binding was 3-6% of total 
binding at 2 nM. Scatchard plot was well fitted to a 
simple linear regression (r = -0.923, P < 0.001) and 
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n H approximated 1 (Fig. 2B), indicating a single popu- 
lation of binding sites. The binding parameters  from 
experiments with 3 animals yielded a g d of 4.59 _ 0.47 
nM and Bma x of 4.83 _+ 0.13 p m o l / m g  protein (mean _ 
S.E.M.) in cortical lamina IV. 
3.2. Effects of picrotoxin, isoguvacine and bicuculline 
Compounds which modulate the activity of the 
G A B A  A receptor complex modulated binding of 
[3H]EBOB. Picrotoxin produced dose-dependent  inhi- 
bition with an ICs0 of 600 nM and saturation analysis 
performed in the presence of 600 nM picrotoxin indi- 
cated a competitive interaction (Figs. 2B, 3, and 4). 
The n H for picrotoxin was 1.40 -t- 0.04 (mean +_ S.E.M) 
and significantly greater  than 1 ( P  < 0.0005 on t-test). 
The G A B A  g agonist, isoguvacine, also produced dose- 
dependent  inhibition of [3H]EBOB binding in all areas 
examined, but there were regional differences in isogu- 
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Fig. 2. A: Saturation curves for [3H]EBOB binding to cortical lami- 
nae V-VI. Sections were incubated in concentrations of [3H]EBOB 
ranging from 10 pM to 10 nM for 120 min at room temperature and 
then rinsed for 2x 60 rain in buffer at 4°C. Non-specific binding was 
determined in the presence of 200/zM picrotoxin. The graph shows 
the result of a typical experiment. B: Scatchard plots of the specific 
binding data in (A). For the graph, K d = 5.90 nM, Bma x = 4.51 
pmol/mg protein and n H = 1.01. In separate experiments, 600 nM 
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Fig. 3. Inhibition of [3H]EBOB binding to cortical lamina IV by 
picrotoxin and isoguvacine. Sections were incubated in 2 nM 
[3H]EBOB in the presence of increasing concentrations of picrotoxin 
and isoguvacine. For picrotoxin, ICs0 = 588 ± 37 nM and n H = 1.40 ± 
0.04. For isoguvacine, ICs0 = 12.3 ± 0.97/zM. Data represent mean ± 
S.E.M. of 3 animals. 
vacine inhibition of [3H]EBOB binding (Figs. 3 and 4). 
ICs0 values for isoguvacine were significantly different 
among brain regions (P  < 0.0001 on ANOVA,  Table 1) 
with ICs0 values lowest in cortical laminae I-III ,  hip- 
pocampal  CA1 stratum radiatum and dentate gyrus, 
septum and the cerebellar molecular and granule cell 
layers. Relatively low ICs0 values were observed also in 
cortical laminae IV, thalamus, inferior colliculus and 
periaqueductal  gray matter.  Relatively high ICs0 values 
were found in cortical laminae V-VI, hippocampal 
CA1 stratum oriens and CA3 stratum oriens, striatum 
and superior colliculus. Bicuculline produced a region- 
ally specific increase in [3H]EBOB binding that was 
restricted to the cerebellar granule cell layer. The 
enhancement  of binding by bicuculline was greater  in 
the inner zone of the granule cell layer than in the 
outer zone of the granule cell layer. In this experiment, 
we paid particular attention to the regional hetero- 
geneity of allosteric modulation of [3H]EBOB binding 
in the cerebellar granule cell layer and carefully ana- 
lyzed the autoradiographs (Fig. 5). In the presence of 
50 /zM bicuculline, the enhancement  of binding was 
90% in the outer zone and 244% in the inner zone of 
the granule cell layer. Significant difference in the 
enhancement  by bicuculline was noted between the 
two zones ( P  < 0.05 on t-test). Such zonally different 
modulation of [3H]EBOB binding in the granule cell 
layer was found to some extent in experiments pre- 
washed in buffer without EDTA,  but not in inhibition 
experiments with picrotoxin. In sections prewashed in 
buffer without EDTA,  [3H]EBOB binding in the 
molecular layer and outer granule cell layer was re- 
duced relative to binding in the granule cell layer 
bordering the white matter.  
3.3. Regional distribution of [ 3H]EBOB binding sites 
The regional distribution of [3H]EBOB binding sites 
was heterogeneous (Table 2). High levels of binding 
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were found in lamina IV of neocortex, the pre/para-  
subiculum of the hippocampal formation; intermediate 
levels of binding were found in laminae I-III of neocor- 
tex, laminae V-VI of neocortex, most areas of hip- 
pocampal formation, superior colliculus, inferior col- 
liculus, periaqueductal gray matter, the cerebellar 
molecular layer; and low levels of binding in septum, 
striatum, thalamus, the cerebellar granule cell layer. 
This distribution pattern was virtually identical with 
that of [3H]TBOB binding sites. Correlation of the 
regional distribution of [3H]EBOB binding sites with 
the regional distribution of [3H]TBOB binding sites 
revealed significant correlation (Fig. 6). 
Highest levels of binding were seen in the granule cell 
layer bordering the white matter (0.62 + 0.044 pmol/  
mg protein) and specific binding was 94% of total 
binding. The distribution of [3H]EBOB binding in hu- 
man cerebellar cortex was different from that found in 
rat cerebellar cortex, where [3H]EBOB binding was 
always higher in the molecular layer than in the gran- 
ule cell layer. While [3H]EBOB demonstrated a high 
specific binding in human brain tissue, specific 
[3H]TBOB binding to the human cerebellar cortex was 
quite low and sometimes indistinguishable from its 
non-specific binding (data not shown). 
3.4. Human cerebellar cortex 4. Discussion 
Specific [3H]EBOB binding sites were found within 
the human cerebellar cortex (Fig. 7). The distribution 
of binding sites was heterogeneous, with higher levels 
of binding in the granule cell layer (mean 0.44 + 0.026 
(S.E.M.) pmol/mg protein) and lower levels in the 
molecular layer (0.060 + 0.0086 pmol/mg protein). 
4.1. [3H]EBOB binding 
[3H]EBOB is a suitable radioligand for quantitative 
autoradiography of picrotoxin binding sites. The EDTA 
prewash has been shown to be more efficient in remov- 
ing endogeneous tissue GABA than conventional pre- 




Fig. 4. Autoradiographs of [3H]EBOB binding to horizontal section of rat brain without modulation (A), in the presence of 600 nM picrotoxin (B) 
and in the presence of 10 p.M isoguvacine (C). Sections were incubated in 2 nM [3HIEBOB. Co-incubation with 600 nM picrotoxin decreased 
[3H]EBOB binding to the cortical laminae I-III, laminae V-VI, hipocampal CA1 stratum oriens, inferior colliculus and cerebellar molecular layer 
by 51, 55, 55, 64, 64%, respectively. Co-incubation with 10 ~M isoguvacine decreased the binding by 96, 35, 16, 43, 100%, respectively. Picrotoxin 
displaced to a similar extent all of the [3H]EBOB bound in all of the brain regions, but there were regional differences in isoguvacine inhibition 
of [3H]EBOB binding. I-III: cortical laminae I-III, IV: cortical lamina IV, V-VI: cortical laminae V-VI, CAI: CA1 stratum oriens, CA3:CA3 
stratum oriens, CNTL: control, DG: dentate gyrus, Gr: cerebellar granule cell layer, IC: inferior colliculus, ISO: isoguvacine, Mol: cerebellar 
molecular layer, PAG: periaqueductal gray matter, PIC: picrotoxin, SC: superior colliculus, Sep: septum, Str: striatum, Thai: thalamus. 
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Table 1 
Inhibition of [3H]EBOB binding in various brain regions by isogu- 
vacine 
Brain region IC50 (~M) 
With high sensitivity to isoguvacine 
Neocortex 
Laminae I-III 4.1 + 0.7 
Hippocampus 
CA1 stratum radiatum 3.4 + 0.7 
Dentate gyrus 4.6 + 0.5 
Septum 1.1 + 0.3 
Cerebellum 
Molecular layer 1.7 + 0.5 
Granule cell layer 
Outer zone 0.8 + 0.1 
Inner zone 0.6 + 0.2 
With intermediate sensitivity to isoguvacine 
Neocortex 
Lamina IV 12.0 + 1.9 
Hippocampus 
CA3 stratum radiatum 8.5 + 1.0 
Pre/para subiculum 8.2 + 0.5 
Thalamus 7.8 + 1.2 
Inferior colliculus 12.7 5:1.2 
Periaqueductal gray matter 9.0 + 1.1 
With low sensitivity to isoguvacine 
Neocortex 
Laminae V-VI 17.6 5= 0.9 
Hippocampus 
CA1 stratum oriens 27.9 5:4.6 
CA3 stratum oriens 15.3 + 2.0 
Striatum 23.1 + 2.7 
Superior colliculus 24.0 + 2.4 
ICs0 values were derived from inhibition curves with isoguvacine. 
Data are mean + S.E.M. values from experiments with n = 3 animals. 
A significant difference of the IC50 values among regions is noted on 
one-way ANOVA (P < 0.0001). 
EBOB is 4- to 5-fold lower than those of [35S]TBPS 
(Squires et al., 1983; Edgar and Schwartz, 1990), 2- to 
10-fold lower than those of [3H]TBOB (Lawrence et 
al., 1985; Van Rijn et al., 1990) and virtually 6-fold 
lower than those of [3H]TBOB obtained previously in 
our laboratory (Kume et al., 1994; Sakurai et al., 1994). 
Use of [3H]EBOB confers some advantages for quanti- 
A, CNTL 
B. +BIC 
C. no EDTA 
washes and has been shown previously to be necessary 
for [35S]TBPS autoradiography (Edgar and Schwartz, 
1990; Sapp et al., 1992) and [3H]TBOB autoradiog- 
raphy (Sakurai et al., 1994). Likewise, EDTA prewash 
is necessary for optimal [3H]EBOB autoradiography. 
In homogenate studies, investigators have used incu- 
bation times ranging from 60 to 90 min, but the time to 
reach equilibrium was not indicated. Our association 
experiments indicate that an incubation time of 2 h is 
necessary for [3H]EBOB binding to slices to reach 
equilibrium. 
The affinity of [3H]EBOB for slide-mounted sec- 
tions was determined according to saturation analysis; 
K d = 4.59 + 0.47 nM in cortical lamina IV. Our ob- 
served K d values are somewhat higher than that found 
in the homogenate binding using animal and human 
brains (Cole and Casida, 1992; Hawkinson and Casida, 
1992). Differences in K d values may reflect differences 
in binding condition between studies. 
As compared with reported K d values of other 
picrotoxin ligands, our observed K d values of [3H]- 
Mol 
Gr -O  
Gr-I 
Fig. 5. [3H]EBOB binding to the rat cerebellum without modulation 
(A), in the presence of 50/~M bieuculline (B), and prewashed with 
buffer without EDTA (C). All sections were incubated in 2 nM 
[3H]EBOB and then rinsed for 2×60 min in buffer. In control 
sections prewashed with buffer containing 1 mM EDTA, density of 
[3H]EBOB binding was homogeneous through the granule cell layer 
(A). However, in sections co-incubated with bicuculline and sections 
prewashed with buffer without EDTA, [3H]EBOB binding differed 
within the granule cell layer. Co-incubation with 50/zM bicuculline 
enhanced [3H]EBOB binding to the granule cell layer and signifi- 
cantly more so in the inner zone (B). In sections prewashed with 
buffer without EDTA, [3H]EBOB binding in the outer zone of the 
granule cell layer was reduced relative to the binding in the inner 
zone bordering the white matter (C). BIC: bicuculline, CNTL: con- 
trol, Gr-I: inner zone of the granule cell layer, Gr-O: outer zone of 
the granule cell layer, Mol: molecular layer. 
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Table 2 
Regional distribution of [3H]EBOB binding to rat brain sections 
Brain region Specific [3H]EBOB binding 
(pmol/mg protein) 
Mean S.E.M. 






Laminae I-III 1.23 0.012 86 
Lamina IV 1.42 0.058 100 
Laminae V-VI 1.12 0.042 79 
Hippocampus 
CA1 str. oriens 0.91 0.012 64 
CA1 str. radiatum 0.68 0.033 48 
CA3 str. oriens 0.91 0.019 64 
CA3 str. radiarum 0.84 0.022 59 
Dentate gyrus 1.00 0.024 70 
Pre/para subiculum 1.38 0.015 97 
Septum 0.52 0.040 37 
Striatum 0.48 0.029 34 
Thalamus 
Laterodorsal thai. ncl. 0.61 0.044 43 
Latral post. thai. ncl. 0.61 0.039 43 
Superior colliculus 0.96 0.046 68 
Inferior colliculus 1.17 0.091 82 
Periaqueductal gray matter 1.07 0.033 75 
Cerebellum 
Molecular layer 0.85 0.040 60 
Granular cell layer 
Outer zone 0.23 0.011 16 
Inner zone 0.27 0.026 19 
Data represent mean + S.E.M. of 3 animals. Sections were incubated 
in 2 nM [3H]EBOB for 120 min at room temperature and then 
rinsed for 2×60 min in 50 mM Tris-HC1 buffer (pH 7.4 at 4°C). 
Quantification of autoradiograms was performed as described in the 
text. A significant difference of the specific [3H]EBOB binding 
among regions is noted on one-way ANOVA (P < 0.0001). 
tative autoradiography. First, a proper rinse provides 
an optimal autoradiographic image with a high contrast 
to the background because specific, high-affinity bind- 
ing dissociates little while most of non-specific binding 
z 
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Fig. 6. Correlation of [3H]EBOB binding sites with [3H]TBOB was 
determined with linear regression. 
MoI Gr 
Fig. 7. Autoradiograph of [3H]EBOB binding to human cerebellar 
cortex. Sections were incubated in 2 nM [3H]EBOB and then rinsed 
for 2 x 60 min. The human sections were apposed to film for 5 weeks 
in order to obtain a clear visible image. There was a high density of 
[3H]EBOB binding sites in the granule cell layer, and the highest 
density was seen in the inner zone bordering the white matter. Gr: 
granule cell layer, Mol: molecular layer. 
dissociates rapidly. The high quality autoradiograph 
makes it easier to analyze small brain structures and to 
measure subtle changes in binding levels. Second, the 
high-affinity, high-specific-activity radioligand reduces 
the amount necessary for each experiment. Therefore, 
[3H]EBOB is more ecconomical than [3H]TBOB and 
[35S]TBPS, particularly in a large series of pharmaco- 
logical experiments and saturation studies. Third, 
[3H]EBOB showed a high specific binding to human 
brain slices as well as rat brain slices (discussed below). 
[3H]EBOB makes it possible to study human brain 
picrotoxin binding sites. 
4.2. Effects of picrotoxin, isoguvacine and bicuculline 
Previous binding studies have indicated that unla- 
beled EBOB inhibits [35S]TBPS binding to the picro- 
toxin site (Hawkinson and Casida, 1992) and [3H]EBOB 
binding is inhibited by a number of unlabeled com- 
pounds acting at the picrotoxin site, such as picrotoxin, 
lindane, TBPS and dithianes (Dens et al., 1991; Cole 
and Casida, 1992). Scatchard analysis demonstrated 
that lindane and picrotoxin are competitive inhibitors 
of [3H]EBOB binding in the insect brain (Dens et al., 
1991). In the present study, we observed that [3H]- 
EBOB binding to the rat brain slices is inhibited by 
picrotoxin in a competitive manner. Our results sup- 
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port the conclusion that [3H]EBOB binds to the picro- 
toxin site associated with the GABA A receptor com- 
plex. 
We observed regional differences in allosteric effect 
by GABA A compounds on [3H]EBOB binding. Isogu- 
vacine, a GABA A agonist, inhibited [3H]EBOB bind- 
ing in all brain regions but there was a regional differ- 
ence in inhibitory effect by isoguvacine. Bicuculline, a 
GABA A antagonist, enchanced [3H]EBOB binding 
only to the cerebellar granule cell layer while picro- 
toxin uniformly inhibited its binding. Regionally differ- 
ent effects of allosteric modulators on picrotoxin ligand 
binding have been reported with [35S]TBPS and [3H]- 
TBOB (Gee et al., 1988; Sapp et al., 1992; Korpi et al., 
1992; Korpi and Liiddens, 1993; Kume et al., 1994; 
Sakurai et al., 1994). The pharmacological and molecu- 
lar biological evidence for regional heterogeneity of the 
GABA A receptor complex has been widely reported 
and regional/cellular differences in the expression of 
GABA A receptor subunit isoforms probably underlie, 
at least in part, regional/cellular differences in recep- 
tor function and pharmacology (Olsen and Tobin, 1990; 
Burt and Kamatchi, 1991). For example, the cerebellar 
granule cells have a unique collection of the GABA A 
receptor subunits (Shivers et al., 1989; Liiddens et al., 
1990) and they are the single type of neuron expressing 
the a6 subunit in adult rat brain (Laurie et al., 1992a, 
b; Thompson et al., 1992). Korpi and Liiddens (1993) 
correlated the GABA A pharmacology in rat brain sec- 
tions with the properties of recombinant receptors 
expressed from various subunit cDNAs selected on the 
basis of their regional expression, and provided evi- 
dence that a greater GABA sensitivity of [35S]TBPS 
binding in the cerebellar granule ceils is inherent to a6 
subunit-containing receptors. In this study, we ob- 
served bicuculline enchancement of [3H]EBOB bind- 
ing only in the cerebellar granule cell layer. This prop- 
erty, a differential coupling of bicuculline sites and 
[3H]EBOB binding sites in cerebellar granule cells, is 
probably determined by the expression of a6 subunit 
conferring exceptional sensitivity to the effects of the 
small amount of GABA remaining in sections after 
prewashes (Korpi and Liiddens, 1993). Thus, the re- 
gional difference in GABA A agonist/antagonist ef- 
fects on [3H]EBOB binding may well reflect the re- 
gional heterogeneity of GABA A isoforms. 
It is interesting that the cerebellar granule cell layer 
showed regional heterogeneity of GABA A agonist/ 
antagonist modulation of [3H]EBOB binding despite 
its anatomically homogeneous appearance. This was 
first noted by Edgar and Schwartz (1990) and con- 
firmed by Korpi and Liiddens (1993). They observed 
that GABA inhibition of [35S]TBPS binding was rela- 
tively less potent in the inner zone of the cerebellar 
granule cell layer. We observed the same phenomenon 
with [3H]EBOB binding. Bicuculline enhanced [3H]- 
EBOB binding to the inner zone twice as much as to 
the outer zone. In sections prewashed with buffers 
without EDTA, where endogeneous GABA remains 
and decreases [3H]EBOB binding, [3H]EBOB binding 
in the outer zone of the granule cell layer was reduced 
relative to binding in the inner zone. These findings 
suggest that GABA and GABA A antagonist regulation 
on [3H]EBOB binding sites differs with location within 
the granule cell layer, although all granule cells are 
histologically similar. A recent in situ hybridization 
study indicated the presence of six subunit mRNAs 
(al ,  a6, f12, /33, y2, 6) in the rat cerebellar granule 
cells and suggested the existence of at least two sub- 
types of pentameric GABA A receptors on the granule 
cells or subtypes of granule cells expressing different 
GABA A receptors (Laurie et al., 1992a). A recent 
immunocytochemical study with antibodies for several 
GABA A receptor subunits on cultured cerebellar gran- 
ule cells predict two subtypes of the GABA A receptor 
with heteropentameric structure (aa/3fly2, ototflfl8 - 
Caruncho et al., 1993). The existence of 2 different 
subtypes of GABA A receptor in granule cells may 
bring about differential GABA and GABA antagonist 
effects on [3H]EBOB binding in the granule cell layer. 
During development, granule cells are generated in 
the external granular layer of the cerebellum and mi- 
grate to their adult position where they will then elabo- 
rate dendrites which will become postsynaptic to the 
axon of the Golgi cells (Altman, 1972a,b; Rakic, 1971). 
Golgi cells form inhibitory GABAergic synapses with 
granule cells in synaptic glomeruli (Palay and Chan- 
Palay, 1974). As granule cells enter the granule cell 
layer, they form an outside-to-inside gradient with the 
early generated cells settling superficial to the newly 
arriving cells. The developing granule cells express 
GABA A receptor subunits only after they have 
achieved their adult position and elaborated dendrites 
(Meinecke and Rakic, 1990; Gambarana et al., 1990; 
Laurie et al., 1992b; Zheng et al., 1993). Therefore, in 
granule cells there probably exists some zonal differ- 
ence of GABAergic synapse formation and expression 
of the GABA A receptor complex. 
4.3. Regional distribution of  [3H]EBOB binding sites 
Reported regional distributions of picrotoxin ligand 
binding sites, such as [35S]TBPS and [3H]TBOB bind- 
ing sites (Gee et al., 1983; Lawrence et al., 1985; Edgar 
and Schwartz, 1990; Olsen et al., 1990; Sakurai et al., 
1994), are heterogeneous. Our quantitative autoradiog- 
raphy demonstrated also regional heterogeneity of 
[3H]EBOB binding sites. The regional distribution pat- 
tern of [3H]EBOB binding sites was virtually identical 
with that of [3H]TBOB binding sites. This suggests that 
[3H]EBOB binds exactly to the [3H]TBOB binding site 
and that determinants of [3H]EBOB binding are iden- 
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tical with those of [3H]TBOB binding. In prior studies, 
correlation of regional distribution of [3H]TBOB bind- 
ing sites with those of [3H]zolpidem (Sakurai et al., 
1994) and [3H]2-oxo-quazepam (Olsen et al., 1990) 
suggested that regional expression of benzodiazepine 
type I binding and [3H]TBOB binding have common 
underlying determinants. Sakurai et al. (1994) found a 
number of similarities between regional distribution of 
[3H]TBOB binding sites and that of a l  subunit mRNA 
determined by in situ hybridization, and suggested that 
the presence of a l  subunit is an important determi- 
nant of [3H]TBOB binding. 
Although homogenate binding experiments have in- 
dicated that TBPS and TBOB act at the same popula- 
tion of binding sites (Lawrence et al., 1985), autoradio- 
graphic studies revealed that the regional distribution 
of [3H]TBOB binding sites was somewhat different 
from that of [35S]TBPS binding sites (Olsen et al., 
1990; Sakurai et al., 1994). In this experiment, we 
confirmed a similar discord of the distribution of ligand 
binding sites between [3H]EBOB autoradiography and 
previously reported [35S]TBPS autoradiography (Edgar 
and Schwartz, 1990; Kume et al., unpublished data). 
TBPS, TBOB and EBOB are insecticides with a high 
toxicity and structurally consist of trioxabicyclooctane 
and X-substituents (Palmer and Casida, 1991; Casida, 
1993; Hawkinson and Casida, 1993). The structure- 
toxicity relationships of trioxabicyclooctanes has re- 
vealed a discontinuous size-activity correlation for the 
X-substituents, i.e., high toxicity is conferred by small 
and large substituents and low toxicity by those of 
intermediate size (Milbrath et al., 1979; Palmer and 
Casida, 1988), and two distinct binding sites were 
therefore proposed: one for compounds with small 
X-substituents such as TBPS and one for trioxabicy- 
clooctanes with large X-substituents such as TBOB 
and EBOB. The proposal of two subtypes of binding 
sites for trioxabicyclooctanes is consistent with our 
results of correlation analysis among [35S]TBPS, 
[3H]TBOB and [3H]EBOB binding sites. The hypothe- 
sis of subtypes of picrotoxin binding sites is also consis- 
tent with our picrotoxin competition data. The n H of 
the picrotoxin displacement curve was significantly 
greater than 1, which is consistent with the existence of 
multiple picrotoxin binding sites, although positive co- 
operativity between identical sites is also possible. 
4.4. Human  cerebellar cortex 
Autoradiographic studies of the GABA A receptor 
complex in human cerebellum have reported localiza- 
tion of GABA and benzodiazepine binding sites in 
normal and diseased conditions (Young and Kuhar, 
1979; Whitehouse et al., 1986; Albin and Gilman, 1990; 
Price et al., 1993). However, localization of picrotoxin 
binding sites in human cerebellum is not yet published, 
probably because of the abscence of suitable radioli- 
gands for autoradiographic study. The commonly used 
radioligand, [3H]TBOB, did not make suitable auto- 
radiographs in this experiment. In contrast, [3H]EBOB 
binding displayed excellent results with a high specific 
binding in human cerebellar cortex. A prior ho- 
mogenate binding study revealed that [3H]EBOB has a 
specific binding for human brain tissue as high as or 
higher than that for rodent brain tissue and the affinity 
of [3H]EBOB is more than 10-fold higher than that of 
[3H]TBOB (Cole and Casida, 1992). Those results are 
consistent with our data. The high affinity and high 
specific binding of [3H]EBOB make it possible to per- 
form autoradiographic studies of picrotoxin binding 
sites in human brain. 
We observed a species difference in distribution of 
[3H]EBOB binding sites. In rat cerebellum, there is a 
high density of [3H]EBOB binding sites in the molecu- 
lar layer and a relatively low but significant density in 
the granule cell layer. In the human cerebellum, there 
was a high density of [3H]EBOB binding sites in the 
granule cell layer, but there was a markedly reduced 
level of binding sites in the molecular layer. Similar 
species difference in receptor distribution in the cere- 
bellum is reported for the benzodiazepine site of the 
GABA A receptor complex (Young and Kuhar, 1979; 
Albin and Gilman, 1990), where human brain shows a 
high density of benzodiazepine site in association with 
both the molecular layer and the granule cell layer 
while in the rat cerebellum there is a high density in 
the molecular layer but a markedly reduced level in the 
granule cell layer. Species difference in receptor distri- 
bution may reflect species differences in GABA A re- 
ceptors in the cerebellar cortex. 
In addition, we observed a zonally arranged differ- 
ence in the level of [3H]EBOB binding sites in the 
human cerebellar granule cell layer. The highest den- 
sity was seen in the inner zone bordering the white 
matter. This finding is similar to that found in the rat 
cerebellar granule cell layer. As described above, we 
suppose some zonal difference in GABAergic synapse 
formation and expression of the GABA A receptor 
complex in the rat cerebellar granule cell layer. Like 
rat cerebellar granule cells, human granule cells are 
generated in the external granular layer of the cerebel- 
lum, migrate to their adult position and then mature 
(Rakic and Sidman, 1970). A similar zonal difference 
of GABAergic synapse formation and expression of the 
GABA A receptor complex may underlie the zonally 
arranged difference in density of [3H]EBOB binding 
site in human cerebellar granule cells. 
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